Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs.

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Abstract Text:

J R Curtis,C Martin,K G Saag,N M Patkar,J Kramer,D Shatin,J Allison,M M Braun,

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Publishing Authors By Initials

JR Curtis,C Martin,KG Saag,NM Patkar,J Kramer,D Shatin,J Allison,MM Braun,

For similar peptides: intercellular signaling peptides and proteins: cytokines: monokines: tumor necrosis factor-alpha research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: monokines: tumor necrosis factor-alpha research

PUBMED ID PMID:

MEDLINE DATE:

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Arthritis and rheumatism

VOLUME: 57

Page Numbers: 343-6

Journal Abbreviation: Arthritis Rheum.

ISSN: 0004-3591

DAY: 15

MONTH: Mar

YEAR: 2007

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370605

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Keywords Mesh Terms:

KEYWORDS: Tumor Necrosis Factor-alpha

MESH TERMS: antagonists & inhibitors

Chemical & Substance for Abstract: Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Information

Substance Name: TNFR-Fc fusion protein

Registry Number: 185243-69-0

Grant and Affiliation Information for Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs.

AFFILIATION: University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. jcurtis@uab.edu

Country: United States

AGENCY: United States NIAMS

GRANT: T32-AR-47512-03

ACRONYM: AR

MEDLINETA: Arthritis Rheum

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs Related Publications

• 597.
• A "moving metal mechanism" for substrate cleavage by the DNA repair endonuclease APE-1.
• ASC: what does it measure and predict?
• Actomyosin-mediated statolith positioning and sedimentation in gravisensing plant cells studied in microgravity.
• Acute pancreatitis presenting as sudden, unexpected death: an autopsy-based study of 27 cases.
• Association between a variation in the phosphodiesterase 4D gene and bone mineral density.
• Bioinformatics approaches to classifying allergens and predicting cross-reactivity.
• Computerized digital dermoscopy.
• Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs.
• Developmental regression and autism reported to the Vaccine Adverse Event Reporting System.
• Electronic Band Structure of Monolayer Bi on GaP(110).
• Estrus induction in the bitch using a combination diethylstilbestrol and FSH-P.
• Evolution of hemispheric specialisation of antagonistic systems of management of the body's energy resources.
• Family support for Native Hawaiian women with breast cancer.
• Impact of methodological factors on sperm penetration into cervical mucus in cattle.
• L?'au lapa'au and Western medicine in Hawai'i: experiences and perspectives of patients who use both.
• Mineralization of CCl(4) by the UVC-photolysis of hydrogen peroxide in the presence of methanol.
• Optical characterization of ultrasmall Si nanoparticles prepared through electrochemical dispersion of bulk Si.
• Reducing cancer health disparities in the US-associated Pacific.
• Statistical analysis of physical-chemical properties and prediction of protein-protein interfaces.
• Supports for and barriers to healthy living for Native Hawaiian young adults enrolled in community colleges.
• The involvement of ipsilateral temporoparietal cortex in tactile pattern working memory as reflected in beta event-related desynchronization.
• The tetraspan protein EMP2 regulates expression of caveolin-1.
• The use of anesthesia during evoked potential audiometry in goldfish (Carassius auratus).
• Transcriptional profiling of androgen receptor (AR) mutants suggests instructive and permissive roles of AR signaling in germ cell development.
• Utilization of continuous glucose monitoring in normoglycemic, insulin resistant women: 604: may 30 4:45 PM 5:00 PM.
• VITO-1, a novel vestigial related protein is predominantly expressed in the skeletal muscle lineage.
• Vacuum-ultraviolet photochemically initiated modification of polystyrene surfaces: morphological changes and mechanistic investigations.
• [Botulinum toxin A injection for treatment-refractory giggle incontinence]
• [Stone management in children]